Alembic Ltd — Investor Relations & Filings
Alembic Ltd is a long-standing pharmaceutical enterprise focused on the development, manufacturing, and marketing of generic pharmaceutical products and active pharmaceutical ingredients (APIs). Established in 1907, the company operates through a vertically integrated model, covering the entire value chain from research and development to commercial distribution. Its product portfolio spans several therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, and respiratory treatments. The organization maintains advanced manufacturing facilities and dedicated research centers to support its global supply chain. Alembic serves diverse international markets, providing high-quality formulations and bulk drugs to healthcare providers and partners. The company is recognized for its expertise in fermentation technology and its commitment to meeting international regulatory standards for pharmaceutical production.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Copy of Newspaper Publication | 2026-04-17 | English | |
| Copy of Newspaper Publication | 2026-04-15 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | |
| Trading Window | 2026-03-27 | English | |
| Copy of Newspaper Publication | 2026-02-13 | English | |
| Outcome of Board Meeting | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 42205520 | Copy of Newspaper Publication | 2026-04-17 | English | ||
| 42172805 | Copy of Newspaper Publication | 2026-04-15 | English | ||
| 42204512 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | ||
| 42219965 | Trading Window | 2026-03-27 | English | ||
| 42245314 | Copy of Newspaper Publication | 2026-02-13 | English | ||
| 42178329 | Outcome of Board Meeting | 2026-02-12 | English | ||
| 42210245 | Copy of Newspaper Publication | 2026-02-11 | English | ||
| 42231514 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-01-05 | English | ||
| 42204406 | Updates | 2026-01-01 | English | ||
|
2025
6 filings
| |||||
| 42250544 | Trading Window | 2025-12-26 | English | ||
| 42231020 | Copy of Newspaper Publication | 2025-12-15 | English | ||
| 42248750 | Copy of Newspaper Publication | 2025-11-28 | English | ||
| 42336405 | Copy of Newspaper Publication | 2025-11-11 | English | ||
| 42352559 | Outcome of Board Meeting | 2025-11-10 | English | ||
| 42255022 | Copy of Newspaper Publication | 2025-10-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Astra Industrial Group
Diversified producer of pharmaceuticals, specialty chemical…
|
1212 | SA | Manufacturing |
|
AstraZeneca Pharma India Ltd.
Science-led biopharmaceutical organization focused on oncol…
|
ASTRAZEN | IN | Manufacturing |
|
AstraZeneca PLC
A global, science-led biopharmaceutical company developing …
|
AZN | GB | Manufacturing |
|
Astria Therapeutics, Inc.
Clinical-stage biopharma developing therapies for allergic …
|
ATXS | US | Manufacturing |
|
Asymchem Laboratories (Tianjin) Co., Ltd.
A leading CDMO providing comprehensive, integrated pharmace…
|
6821 | HK | Manufacturing |
|
Asymchem Laboratories (Tianjin) Co., Ltd.
Global CDMO providing integrated CMC services across the dr…
|
002821 | CN | Manufacturing |
|
ATAI Life Sciences N.V.
Develops psychedelic-inspired therapies for mental health d…
|
ATAI | NL | Manufacturing |
|
Atea Pharmaceuticals, Inc.
Clinical-stage biopharma developing oral antiviral therapie…
|
AVIR | US | Manufacturing |
|
Athira Pharma, Inc.
Biopharma firm developing small molecule therapeutics for n…
|
ATHA | US | Manufacturing |
|
Atlas Global Brands Inc.
Global cannabis company spanning cultivation, manufacturing…
|
ATL | CA | Manufacturing |
Alembic Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61312/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61312 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61312 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61312 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61312}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alembic Ltd (id: 61312)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.